References
- Srivastava A, Murari M, Datta NR. Early occurrence of acute myeloid leukemia following adjuvant radiotherapy and higher cumulative dose of cyclophosphamide in carcinoma breast. Indian J Cancer 2004;41:178–180.
- Kaplan HG, Malmgren JA, Atwood M. Leukemia incidence following primary breast carcinoma treatment. Cancer 2004;101:1529–1536.
- Bernasconi P, Orlandi E, Cavigliano P, Calatroni S, Boni M, Astori C, Pagnucco G, Giglio S, Caresana M, Lazzarino M, Bernasconi C. Translocation (8;16) in a patient with acute myelomonocytic leukemia, occurring after treatment with fludarabine for a low-grade non-Hodgkin’s lymphoma. Haematologica 2000;85: 1087–1091 .
- Perot C, Huret JL. t(8;16)(p11;p 1 3). In: Atlas of genetics and cytogenetics in oncology and haematology [internet]. Updated December 1998. Available from http://www/infobiogen.fr/services/chromcancer/Anomalies/t0816.html.
- Verma RS, Babu A. Tissue culture techniques and chromo-some preparation. In: Verma RS, Babu A, editors. Human chromosomes principles and techniques. 2nd ed. New York: Mc Graw-Hill, Inc. 1995. p 6–71.
- Mitelman F. ISCN: An international system for human cytogenetic nomenclature. Basel: S Karger; 1995.
- Ibrahim NK. Leukemogenic effect of chemotherapy in patients with breast carcinoma. Cancer 2004;101:1479–1481.
- Weldon CB, Jaffe BM, Kahn MJ. Therapy-induced leukemias and myledysplastic syndromes after breast cancer treatment: An underemphasized clinical problem. Ann Surg Oncol 2002;9:738–744.
- Praga C, Bergh J, Bliss J, Bonneterre J, Cesana B, Coombes RC, Fargeot P, Folin A, Fumoleau P, Giuliani R, Kerbrat P, Hery M, Nilsson J, Onida F, Piccart M, Shepherd L, Therasse P, Wils J, Rogers D. Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: Correlation with doses of epirubicin and cyclophosphamide. J Chin Oncol 2005;23:4179–4191.
- Park MJ, Park YH, Ahn HJ, Choi W, Paik KH, Kim JM, Chang YH, Ryoo BY, Yang SH. Secondary hematological malignancies after breast cancer chemotherapy. Leukemia Lymphoma 2005;46:1183–1188.
- Smith RE, Bryant J, DeCillis A, Anderson S. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin—cyclophosphamide adjuvant therapy for operable breast cancer: The national surgical adjuvant breast and bowel project experience. J Chin Oncol 2003;21:1195–1204.
- Crump M, Tu D, Shepherd L, Levine M, Bramwell V, Pritchard K. Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: A report from the National Cancer Institute of Canada clinical trials group. J Chin Oncol 2003;21:3066–3071.